However, we show that intranasal immunization with a pre-fusion stabilized Washington strain spike, expressed from the highly attenuated, replication-competent vaccinia virus vector NYVAC-KC, fully protected mice against both death and symptoms after infection with SARS2-N501YMA30. This evidence concerns the gene CALCA and infection.